These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2477546)

  • 21. C-terminal peptides of calcitonin gene-related peptide act as agonists at the cholecystokinin receptor.
    Maton PN; Pradhan T; Moore S
    Peptides; 1990; 11(6):1163-7. PubMed ID: 1708136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue.
    Sugg EE; Serra M; Shook JE; Yamamura HI; Burks TF; Korc M; Hruby VJ
    Int J Pept Protein Res; 1988 Jun; 31(6):514-9. PubMed ID: 2457563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
    Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
    Vinayek R; Jensen RT; Gardner JD
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acini.
    Gardner JD; Walker MD; Martinez J; Priestly GP; Natarajan S; Bodanszky M
    Biochim Biophys Acta; 1980 Jul; 630(3):323-9. PubMed ID: 6156709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological evaluation of JMV180 cholecystokinin analogs.
    Amblard M; Lignon MF; Bernad N; Noel-Artis AM; Hauad L; Laur J; Rodriguez M; Galas MC; Fourmy D; Martinez J
    Ann N Y Acad Sci; 1994 Mar; 713():79-87. PubMed ID: 7514377
    [No Abstract]   [Full Text] [Related]  

  • 27. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin 28 interacts with CCK receptor in brain and pancreas.
    Tahiri-Jouti N; Dufresne M; Viguerie N; Fourmy D; Estève JP; Rivier J; Moroder L; Susini C; Vaysse N
    Neuropeptides; 1991 Jun; 19(2):65-71. PubMed ID: 1719446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of estradiol on pancreatic amylase and cholecystokinin binding in ovariectomized guinea pigs.
    Guo YS; Singh P
    J Steroid Biochem; 1989 Sep; 33(3):459-64. PubMed ID: 2476588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
    Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
    Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological effects of newly synthesized cholecystokinin analogs.
    Verspohl EJ; LaMura M
    Horm Res; 2000; 53(4):177-84. PubMed ID: 11044801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional cholecystokinin receptors are distinguished kinetically by biotinyl-Tyr-Gly-(Thr28,Nle31)CCK(25-33) in rat pancreatic acini.
    Winand J; Poloczek P; Delporte C; Moroder L; Svoboda M; Christophe J
    Biochim Biophys Acta; 1991 Oct; 1080(2):181-90. PubMed ID: 1718434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterization of new cholecystokinin analogues.
    Maletínská L; Lignon MF; Galas MC; Bernad N; Pírková J; Hlavácek J; Slaninová J; Martinez J
    Eur J Pharmacol; 1992 Nov; 222(2-3):233-40. PubMed ID: 1280592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues.
    Lignon MF; Galas MC; Rodriguez M; Martinez J
    Cell Signal; 1990; 2(4):339-46. PubMed ID: 1701321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulatory site of functional GTP binding protein coupled to the high affinity cholecystokinin receptor and phospholipase A2 pathway is on the G beta subunit of Gq protein in pancreatic acini.
    Tsunoda Y; Owyang C
    Biochem Biophys Res Commun; 1995 Jun; 211(2):648-55. PubMed ID: 7540841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel CCK analogs for studying CCK-B receptor.
    Yanaihara C; Kuwahara A; Suzuki M; Hoshino M; Li M; Zheng LQ; Kashimoto K; Takeda Y; Iguchi K; Mochizuki T
    Ann N Y Acad Sci; 1994 Mar; 713():107-17. PubMed ID: 8185151
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulation of cholecystokinin activity by albumin.
    Huang SC; Talkad VD; Fortune KP; Jonnalagadda S; Severi C; Delle Fave G; Gardner JD
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10312-6. PubMed ID: 7479774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for cholecystokinin receptor subtype in endocrine pancreas.
    Verspohl EJ; Hafner B; He X; Knittel JJ
    Peptides; 1994; 15(8):1353-60. PubMed ID: 7535422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
    Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.